Kim Kelderman Power - 22 Sep 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Pres. Diagnostics & Genom
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
22 Sep 2021
Net transactions value
-$434,871
Form type
4
Filing time
24 Sep 2021, 16:30:53 UTC
Previous filing
10 Aug 2021
Next filing
23 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Sale $434,871 -822 -100% $529.04* 0 22 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TECH Stock Options (Right to Buy) 2,652 22 Sep 2021 Common Stock 2,652 $150.78 Direct F2
holding TECH Stock Options (Right to Buy) 7,348 22 Sep 2021 Common Stock 7,348 $150.78 Direct F3
holding TECH Stock Options (Right to Buy) 12,044 22 Sep 2021 Common Stock 12,044 $177.32 Direct F4
holding TECH Stock Options (Right to Buy) 9,033 22 Sep 2021 Common Stock 9,033 $177.32 Direct F5
holding TECH Restricted Stock Units 2,363 22 Sep 2021 Common Stock 2,363 Direct F6, F7
holding TECH Stock Options (Right to Buy) 11,961 22 Sep 2021 Common Stock 11,961 $190.41 Direct F7
holding TECH Stock Options (Right to Buy) 15,948 22 Sep 2021 Common Stock 15,948 $190.41 Direct F8
holding TECH Restricted Stock Units 2,015 22 Sep 2021 Common Stock 2,015 Direct F6, F9
holding TECH Stock Options (Right to Buy) 8,991 22 Sep 2021 Common Stock 8,991 $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 11,988 22 Sep 2021 Common Stock 11,988 $267.87 Direct F10
holding TECH Stock Options (Right to Buy) 8,325 22 Sep 2021 Common Stock 8,325 $267.87 Direct F11
holding TECH Stock Options (Right to Buy) 8,325 22 Sep 2021 Common Stock 8,325 $267.87 Direct F12
holding TECH Restricted Stock Units 1,245 22 Sep 2021 Common Stock 1,245 Direct F6, F13
holding TECH Stock Options (Right to Buy) 4,864 22 Sep 2021 Common Stock 4,864 $481.82 Direct F13
holding TECH Stock Options (Right to Buy) 6,486 22 Sep 2021 Common Stock 6,486 $481.82 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021.
F2 Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F3 Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F4 Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
F5 Fully exercisable.
F6 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F7 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
F9 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10 Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F11 Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F12 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F13 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F14 Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.